Profile
BIAF DHR-PB TMO DHR IDXX A
Company Name bioAffinity Technologies, Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $9.11M $916.76B $160.15B $141.09B $35.45B $30.30B
Employees 0.06K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO Ms. Maria Zannes J.D. Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Jonathan J. Mazelsky Mr. Padraig McDonnell
Ratings
BIAF DHR-PB TMO DHR IDXX A
Quant Rating Score 1 5 3 3 3 3
Quant Rating Strong Sell Strong Buy Neutral Neutral Neutral Neutral
Trading
BIAF DHR-PB TMO DHR IDXX A
Last Close $0.499 $1261.26 $424.24 $197.14 $437.44 $106.28
High 52 $2.82 $1261.26 $624.21 $280.76 $548.53 $154.64
Low 52 $0.26 $1261.26 $419.59 $174.64 $361.04 $99.29
Price vs. 52 Week High -82.3 % 0 % -32.04 % -29.78 % -20.25 % -31.27 %
Price vs. 52 Week Low 91.92 % 0 % 1.11 % 12.88 % 21.16 % 7.04 %
Total Return
BIAF DHR-PB TMO DHR IDXX A
1 Month Return 84.47 % 0 % -17.05 % -6.14 % 3.53 % -10.67 %
3 Month Return -30.16 % 0 % -27.31 % -21.33 % 2.32 % -29.6 %
6 Month Return -64.36 % 0 % -23.47 % -19.66 % -3.09 % -18.37 %
9 Month Return -81.59 % 0 % -30.12 % -28.03 % -6.87 % -22.6 %
YTD Return -45.16 % 0 % -18.45 % -14.12 % 5.8 % -20.89 %
1 Year Return -78.95 % 0 % -26.04 % -20.05 % -12.39 % -22.84 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BIAF DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.57 % 0.38 % 0.57 % - 0.91 %
Dividend Paid and Capex Coverage Ration (TTM) -91.86 % 2.93 % 4.05 % 2.93 % 7.1 % 3.01 %
Dividend Per Share (TTM) - 1.13 % 1.6 % 1.13 % - 0.97 %
Payout Ratio (TTM) - 20.85 % 9.16 % 20.85 % - 21.92 %
Growth
BIAF DHR-PB TMO DHR IDXX A
Asset Growth -20.77 % -8.22 % -1.42 % -8.22 % 1.03 % 10.06 %
Gross Profit Growth 1082.65 % 1.23 % 5.81 % 1.23 % 8.63 % 2.02 %
Revenue Growth 269.68 % -0.06 % 0.05 % -0.06 % 6.46 % -4.73 %
Revenue 3 Year - -21.41 % 12.79 % -21.41 % 25.48 % 8 %
Revenue 5 Year - 29.31 % 75.79 % 29.31 % 69.43 % 36.52 %
Revenue 10 Year - 14.22 % 164.64 % 14.22 % 219.02 % 7.08 %
EBIT Growth 218.36 % -6.52 % 6.97 % -6.52 % 2.84 % 10.22 %
Net Income Growth -13.89 % -18.16 % 5.67 % -18.16 % 5.07 % 3.95 %
Net Income 3 Yeari Growth Per Share 100 % -41.24 % -15.42 % -41.24 % 23.4 % 11.67 %
Net Income 5 Yeari Growth Per Share 100 % 25.73 % 79.48 % 25.73 % 117.19 % 30.32 %
Net Income 10 Yeari Growth Per Share 100 % 42.96 % 248.59 % 42.96 % 493.59 % 197.81 %
Operating Income Growth 218.36 % -6.52 % 6.97 % -6.52 % 2.84 % 10.22 %
Operating Cash Flow Growth (CFG) -20.32 % -6.64 % 3.1 % -6.64 % 2.48 % -1.19 %
Operating 3 Year CFG 100 % -22.42 % -6.33 % -22.42 % 27.28 % 23.6 %
Operating 5 Year CFG 100 % 64.18 % 82.49 % 64.18 % 111.7 % 85.69 %
Operating 10 Year CFG 100 % 69.53 % 244.88 % 69.53 % 379.04 % 182 %
EPS Growth 100 % -17.86 % 6.76 % -17.86 % 6.1 % 5.21 %
EPS Diluted Growth 100 % -17.08 % 7.06 % -17.08 % 6.26 % 5.73 %
Book Value Per Share -100 % -7.44 % 7.15 % -7.44 % 8.46 % 2.3 %
Share Holder 3 Year Equity Growth Per Share 100 % 6.35 % 25.29 % 6.35 % 139.34 % 14.73 %
Share Holder 5 Year Equity Growth Per Share 100 % 58.77 % 74.85 % 58.77 % 840.53 % 34.5 %
Share Holder 10 Year Equity Growth Per Share 100 % 101.9 % 151.37 % 101.9 % 1550.96 % 27.76 %
Dividend Per Share Growth - -6.53 % 12.64 % -6.53 % - 4.82 %
Dividend 3 Year Growth Per Share - 0.35 % 52.23 % 0.35 % - 21.71 %
Dividend 5 Year Growth Per Share - 41.45 % 105.55 % 41.45 % - 44.02 %
Dividend 10 Year Growth Per Share - 221.34 % 158.83 % 221.34 % - 78.77 %
Debt Growth -4.91 % -18.07 % -10.43 % -18.07 % -7.53 % 23.95 %
Free Cash Flow Growth -19.87 % -8.39 % 4.91 % -8.39 % 3.26 % -6.85 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Oct 2024
Profitability
BIAF DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 34.49 % 59.74 % 41.74 % 59.74 % 61.08 % 53.97 %
Return on Assets TTM -138.78 % 4.76 % 6.58 % 4.76 % 26.96 % 10.57 %
Return on Equity TTM -250.88 % 7.47 % 13.34 % 7.47 % 55.82 % 20.95 %
Return on Capital Employed TTM -262.66 % 6.66 % 8.53 % 6.66 % 50.78 % 14.73 %
Net Income Per EBT TTM 100.13 % 83.59 % 92.18 % 83.59 % 80 % 84.78 %
EBT Per Ebit TTM 100.83 % 93.35 % 96.45 % 93.35 % 98.21 % 100.34 %
EBIT Per Revenue TTM -95.64 % 20.26 % 17.08 % 20.26 % 28.99 % 22.65 %
Cash Flow To Debt Ratio TTM -483.93 % 37.92 % 23.81 % 37.92 % 94.13 % 50.46 %
Receivables Turnover TTM 8.22 6.79 5.07 6.79 6.94 4.92
Payables Turnover TTM 6.21 5.57 - 5.57 13.28 5.5
Inventory Turnover TTM 222.15 3.79 4.78 3.79 3.97 3.02
Fixed Asset Turnover TTM 578.16 % 466.14 % 459.74 % 466.14 % 470 % 359.75 %
Asset Turnover TTM 143.73 % 30.11 % 43.31 % 30.11 % 118.34 % 54.83 %
Operating Cash Flow Per Share TTM -0.59 8.72 21.53 8.72 11.29 5.95
Free Cash Flow Per Share TTM -0.59 6.84 17.79 6.84 9.7 4.94
Cash Per Share TTM 8.92 % 278.24 % 1573.28 % 278.24 % 350.25 % 514.74 %
Operating Cash Flow Sales Ratio TTM -77.6 % 26.23 % 18.97 % 26.23 % 23.84 % 25.98 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.09 % 78.46 % 82.61 % 78.46 % 85.91 % 83.03 %
Cash Flow Coverage Ratios TTM -483.93 % 37.92 % 23.81 % 37.92 % 94.13 % 50.46 %
Price To Free Cash Flows Ratio TTM -1.24 28.78 23.82 28.78 44.42 21.51
Price To Operating Cash Flows Ratio TTM -0.85 22.6 19.7 22.6 38.75 17.85
Price Cash Flow Ratio TTM -0.85 22.6 19.7 22.6 38.75 17.85
Income Statement (TTM)
BIAF DHR-PB TMO DHR IDXX A
Revenue $0.01B
Gross Profit $0B
Gross Profit Ratio 36.09%
EBITDA $-0.01B
Net Income $-0.01B
EPS Diluted -0.73
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 106.28
ACRS Aclaris Therapeutics, Inc. 1.34
ADVB Advanced Biomed Inc. Common Stock 1.81
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 0.8471
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 0.539
BIAFW bioAffinity Technologies, Inc. 0.1711
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 4.3
BNR Burning Rock Biotech Limited 2.84
CDNA CareDx, Inc 18.48
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.79
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 114.66
CSTL Castle Biosciences, Inc. 20.63
DGX Quest Diagnostics Incorporated 173.76
DHR Danaher Corporation 197.14
ETFs With Exposure to BIAF
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 270.64
VXF Vanguard Extended Market Index Fund 0 170
VTSAX Vanguard Total Stock Market Index Fund 0 131.81
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 128.99
VITSX Vanguard Total Stock Market Index Fund 0 131.83
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 129
VEMPX Vanguard Extended Market Index InstlPlus 0 318.32
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 247.3
Unlock